Vanda Pharmaceuticals Inc. License Agreements

18 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License Agreement among Vanda Pharmaceuticals Inc., MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, and Impax Laboratories LLC (January 13, 2022)
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2022
License Agreement Between Vanda Pharmaceuticals Inc. and Apotex Inc. and Apotex Corp.
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2017
License Agreement between Vanda Pharmaceuticals Inc. and Taro Pharmaceuticals USA, Inc. and Taro Pharmaceutical Industries Ltd. (October 24, 2016)
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2017
Royalty Payment and Amendment Agreement among Titan Pharmaceuticals, Aventisub LLC (Sanofi-Aventis), and Vanda Pharmaceuticals (February 2, 2016)
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2016
License Agreement between Novartis Pharma AG and Vanda Pharmaceuticals Inc.
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2015
Amendment No. 3 to Sublicense Agreement among Titan Pharmaceuticals, Inc. and Novartis Pharma AG
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2015
Amendment No. 2 to Sublicense Agreement between Titan Pharmaceuticals, Inc. and Novartis Pharma A.G.
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2015
Tenth Amendment to Amended and Restated License, Development and Commercialization Agreement between Vanda Pharmaceuticals Inc. and Bristol-Myers Squibb Company
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2013
License, Development and Commercialization Agreement between Eli Lilly and Company and Vanda Pharmaceuticals Inc. (April 12, 2012)
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
IN
2012
Ninth Amendment to Amended and Restated License, Development and Commercialization Agreement between Vanda Pharmaceuticals Inc. and Bristol-Myers Squibb Company
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2012
Amendment to Amended and Restated License, Development and Commercialization Agreement between Vanda Pharmaceuticals Inc. and Bristol-Myers Squibb Company
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2010
Amended and Restated Sublicense Agreement between Novartis Pharma AG and Vanda Pharmaceuticals Inc.
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2010
NDD-094 License Agreement between Novartis Pharma AG, Novartis AG, and Vanda Pharmaceuticals, Inc.
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2006
Amended and Restated License, Development and Commercialization Agreement between Bristol-Myers Squibb Company and Vanda Pharmaceuticals, Inc.
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2006
Sublicense Agreement between Novartis Pharma AG and Vanda Pharmaceuticals, Inc.
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2006
NDD-094 License Agreement between Novartis Pharma AG, Novartis AG, and Vanda Pharmaceuticals, Inc.
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2006
Amended and Restated License, Development and Commercialization Agreement between Bristol-Myers Squibb Company and Vanda Pharmaceuticals, Inc.
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2006
Sublicense Agreement between Novartis Pharma AG and Vanda Pharmaceuticals, Inc. (Iloperidone)
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2006